We are international
Donate
TEXT SIZE   


Aurora-kinase Inhibition for Tailored Risk-Adapted Treatment of Multiple Myeloma
By Dirk Hose, M.D.
XIIth International Myeloma Workshop in Washington, DC
Dirk Hose, M.D.
MD Anderson Cancer Center
Houston, Texas
02.23.09



XIIth International Myeloma Workshop in Washington, DC - On-Demand Only
Session: Clinical - Basic Biology - Research II
Chairs: Douglas Joshua, M.D., Qing Yi, M.D.

February 28, 2009, 13:30 - 13:45 Eastern Standard Time


Aurora-kinase Inhibition for Tailored Risk-Adapted Treatment of Multiple Myeloma
Dr. Dirk Hose
MD Anderson Cancer Center, Houston, TX

 


Back to the Meeting Index


 related articles